Vietnam is set to become one of 10 low- and middle-income countries worldwide with the capacity to develop and produce #mRNA vaccines — a type of vaccine that can be rapidly developed to protect people against new diseases.
POLYVAC (Center for Vaccine and Medical Biological Production and Research), established by the Ministry of Health in 1994, is currently producing vaccines for measles, rubella, polio, and rotavirus-caused diarrhea. Currently, through cooperation with the WHO and the United Nations' Medicines Patent Pool, POLYVAC is building capacity to be able to domestically produce safe and effective mRNA vaccines by 2029, meeting the public health protection needs against future disease outbreaks and pandemics.
This week, Vietnam welcomed a delegation from the French Ministry for Europe and Foreign Affairs led by Mr. Georges-Fabrice Blum – Special Envoy for Health – to discuss progress, challenges, and visit POLYVAC's facilities. France is one of the key donors and partners of the mRNA Technology Transfer Program.
Vietnam's commitment and pioneering role in vaccine innovation demonstrate that global cooperation, combined with domestic efforts, can create sustainable changes in health equity.
